Search research articles
Contact Us
Filters
Showing results (271-280 of 290) with videos related to
Page
of 29
Sort By:
Journal of Diabetes Science and Technology
|
February 11, 2010
Temporal and geographic patterns of hypoglycemia among hospitalized patients with diabetes mellitus
Rachel M Bailon, Curtiss B Cook, Michael J Hovan, et al.
Cancer Research
|
April 4, 2015
Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors
Noah A Cohen, Shan Zeng, Adrian M Seifert, et al.
Prostate Cancer and Prostatic Diseases
|
February 21, 2012
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression
C A Derosa, B Furusato, S Shaheduzzaman, et al.
The Journal of Antimicrobial Chemotherapy
|
May 11, 2018
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate
Christine E MacBrayne, Kristen M Marks, Daniel S Fierer, et al.
British Journal of Cancer
|
March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
G Pfeiler, H Stöger, P Dubsky, et al.
The Journal of Experimental Medicine
|
December 11, 2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarization
Michael J Cavnar, Shan Zeng, Teresa S Kim, et al.
Oncogene
|
February 10, 2022
Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases
Venkatesh Sadananda Rao, Qianyu Gu, Sandra Tzschentke, et al.
Cancer Immunology Research
|
February 23, 2018
Macrophages and CD8<sup>+</sup> T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Jennifer Q Zhang, Shan Zeng, Gerardo A Vitiello, et al.
Iscience
|
December 1, 2025
Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancer
David Digomann, Charlotte Reiche, Antonia Stammberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor
Teresa S Kim, Michael J Cavnar, Noah A Cohen, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 290) with videos related to
Sort By:
Page
of 29
Journal of Diabetes Science and Technology
|
February 11, 2010
Temporal and geographic patterns of hypoglycemia among hospitalized patients with diabetes mellitus
Rachel M Bailon, Curtiss B Cook, Michael J Hovan, et al.
Cancer Research
|
April 4, 2015
Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors
Noah A Cohen, Shan Zeng, Adrian M Seifert, et al.
Prostate Cancer and Prostatic Diseases
|
February 21, 2012
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression
C A Derosa, B Furusato, S Shaheduzzaman, et al.
The Journal of Antimicrobial Chemotherapy
|
May 11, 2018
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate
Christine E MacBrayne, Kristen M Marks, Daniel S Fierer, et al.
British Journal of Cancer
|
March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
G Pfeiler, H Stöger, P Dubsky, et al.
The Journal of Experimental Medicine
|
December 11, 2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarization
Michael J Cavnar, Shan Zeng, Teresa S Kim, et al.
Oncogene
|
February 10, 2022
Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases
Venkatesh Sadananda Rao, Qianyu Gu, Sandra Tzschentke, et al.
Cancer Immunology Research
|
February 23, 2018
Macrophages and CD8<sup>+</sup> T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Jennifer Q Zhang, Shan Zeng, Gerardo A Vitiello, et al.
Iscience
|
December 1, 2025
Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancer
David Digomann, Charlotte Reiche, Antonia Stammberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor
Teresa S Kim, Michael J Cavnar, Noah A Cohen, et al.
Page
of 29